Galiè, N., Jansa, P., Pulido, T., Channick, R. N., Delcroix, M., Ghofrani, H.-A., … Torbicki, A. (2017). SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal, 38(15), 1147–1155. https://doi.org/10.1093/eurheartj/ehx025

Galiè, Nazzareno, Pavel Jansa, Tomás Pulido, Richard N. Channick, Marion Delcroix, Hossein-Ardeschir Ghofrani, Franck-Olivier Le Brun, et al. “SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.” European Heart Journal 38, no. 15 (April 14, 2017): 1147–55. https://doi.org/10.1093/eurheartj/ehx025.

Galiè N, Jansa P, Pulido T, Channick RN, Delcroix M, Ghofrani H-A, et al. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal. 2017 Apr 14;38(15):1147–55.

Galiè, Nazzareno, et al. “SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.” European Heart Journal, vol. 38, no. 15, Oxford University Press (OUP), Apr. 2017, pp. 1147–55. Crossref, doi:10.1093/eurheartj/ehx025.

Galiè N, Jansa P, Pulido T, Channick RN, Delcroix M, Ghofrani H-A, Le Brun F-O, Mehta S, Perchenet L, Rubin LJ, Sastry BKS, Simonneau G, Sitbon O, Souza R, Torbicki A. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension. European Heart Journal. Oxford University Press (OUP); 2017 Apr 14;38(15):1147–1155.